About 3D Global Biotech
3D Global Biotech is a company based in Taipei (Taiwan) founded in 2014.. 3D Global Biotech operates in a competitive market with competitors including MiMedx Group, Reprise Biomedical, pacifymedical, Rapid Graft and Hans Biomed, among others.
- Headquarter Taipei, Taiwan
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name 3D Global Biotech Inc.
-
Annual Revenue
$0 (USD)1187.68as on Dec 31, 2024
-
Net Profit
$0 (USD)0as on Dec 31, 2024
-
EBITDA
$0 (USD)0as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of 3D Global Biotech
3D Global Biotech is a publicly listed company on the TPEX with ticker symbol 6808 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of 3D Global Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by 3D Global Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - 3D Global Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
3D Global Biotech Comparisons
Competitors of 3D Global Biotech
3D Global Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MiMedx Group, Reprise Biomedical, pacifymedical, Rapid Graft and Hans Biomed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics
|
|
| domain | founded_year | HQ Location |
Developer of surgical mesh for wound management
|
|
| domain | founded_year | HQ Location |
Skin-spraying devices for advanced wound care are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Split-skin grafts are developed for chronic wound treatment.
|
|
| domain | founded_year | HQ Location |
Allograft tissues, biomaterials, and skin cell treatments are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative medicines from human tissues are developed for multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about 3D Global Biotech
When was 3D Global Biotech founded?
3D Global Biotech was founded in 2014.
Where is 3D Global Biotech located?
3D Global Biotech is headquartered in Taipei, Taiwan.
What does 3D Global Biotech do?
3D Global Biotech was founded in 2014 in Taipei, Taiwan, within the biotechnology sector. Human tissues and organ reconstructed implants are developed, with emphasis on soft tissue products and hard tissues. Operations include bone remodeling, bone reconstruction, dental reconstruction, cranioplasty, bio-inks, hydrogels, and corneal epithelial reconstruction. The company operates from its base in Taiwan, targeting regenerative medicine applications.
Who are the top competitors of 3D Global Biotech?
3D Global Biotech's top competitors include MiMedx Group, Reprise Biomedical and pacifymedical.
Is 3D Global Biotech publicly traded?
Yes, 3D Global Biotech is publicly traded on TPEX under the ticker symbol 6808.
What is 3D Global Biotech's ticker symbol?
The ticker symbol of 3D Global Biotech is 6808 on TPEX.